MANGOCEUTICALS INC
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
MGRX$0.20+1.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statement of Changes in Stockholders’ Equity (Deficit)
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)
For the Three Months Ended March 31, 2024 and 2023
| Common Stock · Additional Paid-in · Accumulated · Accumulated Comprehensive · Non-Controlling · Total Stockholders’ Equity | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Capital · Deficit · Loss · Interest · (Deficit) | |||||||||
| Balance, December 31, 2022 | 13,365,000 | $1,337 | $2,628,449 | $(2,015,756) | $ | - | $ | - | $614,030 |
| Issuance of common stock for services | 700,000 | 70 | 699,930 | - | - | - | $700,000 | ||
| Issuance of common stock for cash | 1,250,000 | 125 | 4,999,875 | - | - | - | $5,000,000 | ||
| Imputed interest | - | - | 1,760 | - | - | - | $1,760 | ||
| Options and warrants vested for services | - | - | 64,271 | - | - | - | $64,271 | ||
| Net loss | - | - | - | (2,560,885) | - | - | (2,560,885) | ||
| Balance, March 31, 2023 | 15,315,000 | $1,532 | $8,394,285 | $(4,576,641) | $ | - | $ | - | $3,819,176 |
| Balance, December 31, 2023 | 21,419,500 | 2,142 | $12,000,785 | $(11,228,173) | $ | - | $ | - | $774,754 |
| Issuance of common stock for services | 1,600,000 | 160 | 416,340 | - | - | - | 416,340 | ||
| Issuance of common stock for cash | 600,000 | 60 | 179,940 | - | - | - | 180,000 | ||
| Options and warrants vested for services | - | - | 37,965 | - | - | - | 37,965 | ||
| Translation adjustment | - | - | - | - | (70) | - | (70) | ||
| Net loss | - | - | - | (2,367,581) | - | (36) | (2,367,617) | ||
| Balance, March 31, 2024 | 23,619,500 | $2,362 | $12,635,030 | $(13,595,754) | $(70) | $(36) | $(958,468) | ||
MANGOCEUTICALS, INC.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.